UBS’s Calpine Corporation CPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$16.1M Sell
742,991
-23,163
-3% -$524K 0.01% 1095
2014
Q2
$18.2M Sell
766,154
-52,322
-6% -$1.19M 0.01% 937
2014
Q1
$17.1M Sell
818,476
-178,337
-18% -$3.5M 0.02% 889
2013
Q4
$19.4M Sell
996,813
-136,954
-12% -$2.66M 0.02% 825
2013
Q3
$22M Sell
1,133,767
-238,420
-17% -$4.73M 0.02% 667
2013
Q2
$29.1M Buy
+1,372,187
New +$28.8M 0.03% 488

Other funds holding CPN

UBS's CPN Position: Q3 2014 in Review

UBS reduced its Calpine Corporation (CPN) stake by 3% in Q3 2014, selling an estimated $524K and leaving 742,991 shares worth $16.1M. The position accounts for 0.01% of the portfolio, ranked #1095.

UBS first reported a position in CPN in Q2 2013 and has held it in 6 quarters since. The position peaked at $29.1M in Q2 2013. 315 funds tracked by Wall St. Rank hold CPN as of Q3 2014.

  • UBS held 742,991 shares of Calpine Corporation worth $16.1M as of Q3 2014.
  • UBS sold 23,163 Calpine Corporation shares in Q3 2014, an estimated $524K.
  • Calpine Corporation made up 0.01% of UBS's portfolio in Q3 2014, its #1095 holding.
  • UBS first reported a position in Calpine Corporation in Q2 2013 and has held it in 6 quarters since.
  • UBS's Calpine Corporation position peaked at $29.1M in Q2 2013.
  • 315 funds tracked by Wall St. Rank held Calpine Corporation as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.